EKNOX  /  Regulatory
Registration & Authorization

Authorization is the threshold everything depends on.

A product is only a candidate until an authority approves it. Eknox compiles, submits and maintains market-authorization dossiers across diverse regulatory systems — built on rigorous evidence and a close reading of each authority's expectations.

The Pathway

How an authorization is earned.

Phase 01

Gap Assessment

We measure the product and its dossier against each target authority's requirements.

Phase 02

Dossier Compilation

We assemble or remediate the CTD dossier — quality, safety, efficacy and administrative evidence.

Phase 03

Submission & Liaison

We submit and manage queries, deficiencies and timelines through to decision.

Phase 04

Authorization & Launch

On approval, we coordinate importation, distribution and market entry.

Phase 05

Lifecycle Maintenance

We manage renewals, variations and pharmacovigilance for the life of the product.

One body of evidence, many markets — assembled so a product can move from one jurisdiction to the next without rebuilding its case each time.

Auditable by design

Every submission rests on an ALCOA+ documented trail, built to satisfy the receiving authority.

The CTD Dossier

Structured to the common standard.

Module 1

Administrative

Regional administrative and prescribing information for each authority.

Module 2-3

Quality

Chemistry, manufacturing and controls — the quality backbone of the dossier.

Module 4

Safety

Non-clinical study reports supporting the safety profile.

Module 5

Efficacy

Clinical study reports supporting efficacy and use.

Authorities

The regulators we work with.

We submit to, liaise with, and maintain authorizations across national medicines authorities and continental frameworks — meeting each on its own terms.

NAFDACNigeria
SAHPRASouth Africa
PPBKenya
TMDATanzania
NDAUganda
Rwanda FDARwanda
ZAMRAZambia
MCAZZimbabwe
BoMRABotswana
NMRCNamibia
PMRAMalawi
DIGEMIDPeru
AGEMEDBolivia
GA-FDDGuyana
WHO-PQPrequalification
AMAAfrican Medicines Agency
Questions

What partners ask.

We are engaged across 19 nations in Africa and three in South America, working with their respective medicines authorities, and the model is built to extend to new markets. If a target market is not yet in the network, we assess feasibility and build the pathway.

Yes. We tailor the route — medicine, supplement, botanical, natural product or device — to each product's classification in each market.

We assemble new CTD dossiers or remediate and re-strategize existing ones to meet a specific authority's expectations.

Every engagement is governed by FCPA, UK Bribery Act and OFAC sanctions controls, documented due diligence, and ALCOA+ data integrity.

Engage Eknox

Tell us what needs authorization, and where.

Send your product and target markets — we will map the pathway to approval.